Cell-permeable Tat-NBD peptide attenuates rat pancreatitis and acinus cell inflammation response

doi:10.3748/wjg.15.561

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 5

This Article

(0)

(5061)

(11)

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Original Article

World J Gastroenterol. Feb 7, 2009; 15(5): 561-569
Published online Feb 7, 2009. doi: 10.3748/wjg.15.561

Full Size Figure Download Figure

Figure 2 Pancreas histopathologic scores. The pretreatment of NBD peptide and Tat-NBD (WT) resulted in a significant reduction of the tissue damage score and more beneficial effect can be seen in the latter group at the two time points. Pretreatment with Tat or Tat-NBD (MT) peptide showed no therapeutic effect.

Citation: Long YM, Chen K, Liu XJ, Xie WR, Wang H. Cell-permeable Tat-NBD peptide attenuates rat pancreatitis and acinus cell inflammation response. World J Gastroenterol 2009; 15(5): 561-569
URL: https://www.wjgnet.com/1007-9327/full/v15/i5/561.htm
DOI: https://dx.doi.org/10.3748/wjg.15.561

Long YM, Chen K, Liu XJ, Xie WR, Wang H. Cell-permeable Tat-NBD peptide attenuates rat pancreatitis and acinus cell inflammation response. World J Gastroenterol 2009; 15(5): 561-569 [PMID: 19195057 DOI: 10.3748/wjg.15.561]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.